ABS moulding compositions
    101.
    发明授权

    公开(公告)号:US4009226A

    公开(公告)日:1977-02-22

    申请号:US570350

    申请日:1975-04-22

    摘要: Moulding compositions containingA. 6 to 30 parts by weight of graft polymer obtained by grafting 20 to 60 parts by weight of a mixture of styrene and acrylonitrile in a ratio by weight of 95 : 5 to 60 : 40 onto 80 to 40 parts by weight of polybutadiene or a butadiene copolymer with a butadiene content of at least 30% with an average particle diameter of 0.26 to 0.65.mu. and a grafting degree of 0.15 to 0.7;B. 14 to 45 parts by weight of a graft polymer obtained by polymerizing 40 to 60 parts by weight of a mixture of styrene and acrylonitrile in a ratio by weight of 95 : 5 to 60 : 40 onto 60 to 40 parts by weight of polybutadiene or a butadiene copolymer with a butadiene content of at least 30%, with an average particle diameter of 0.05 to 0.25.mu. and a grafting degree of 0.4 to 0.9; andC. 25 to 80 parts by weight of a copolymer of styrene and/or .alpha.-methyl styrene on the one hand and acrylonitrile on the other hand in a ratio by weight of 80 : 20 to 60 : 40 and an average molecular weight (mean weight) M.sub.w of 50,000 to 200,000 and a molecular heterogeneity of U = 4.5 to 1.0.

    Removing Cells from an Organism
    103.
    发明申请
    Removing Cells from an Organism 审中-公开
    从有机体去除细胞

    公开(公告)号:US20130197296A1

    公开(公告)日:2013-08-01

    申请号:US13740817

    申请日:2013-01-14

    IPC分类号: A61N2/00 A61M3/00 A61N2/06

    摘要: A minimally invasive method to eliminate circulating agents from an organism to prevent and treat diseases is disclosed. The method utilizes immunomagnetic methods to concentrate and localize disease-associated agents in a small region of the body. Subsequently, the complexes are removed from the body. Removal of disease-causing or disease-promoting agents (circulating tumor cells, bacteria, viruses and virus-infected cells, certain immune cells) would add a significant new option for intervention of disease progression and supplement other therapeutic options.

    摘要翻译: 公开了一种从生物体中消除循环剂以预防和治疗疾病的微创方法。 该方法利用免疫磁性方法在身体的一小部分中集中和定位疾病相关药物。 随后,将复合物从体内除去。 去除致病或疾病促进剂(循环肿瘤细胞,细菌,病毒和病毒感染的细胞,某些免疫细胞)将为疾病进展的干预增加一个重要的新选择,并补充其他治疗选择。

    Control valve for cryogenic use
    106.
    发明授权
    Control valve for cryogenic use 失效
    低温控制阀

    公开(公告)号:US06321774B1

    公开(公告)日:2001-11-27

    申请号:US09483609

    申请日:2000-01-14

    申请人: Karl-Heinz Ott

    发明人: Karl-Heinz Ott

    IPC分类号: F16K326

    摘要: A motor-driven control valve for cryogenically liquified rocket propellant comprises a valve casing with a co-axial inlet port and outlet port, a slidable regulating sleeve, an electric motor, a gear, a drive chamber within the casing, and a drive transmission in the drive chamber. The regulating sleeve is centrally arranged and slidably mounted and sealed in the valve casing and the drive chamber. Flow slots are circumferentially distributed around the regulating sleeve. The externally mounted motor and gear control the position of the regulating sleeve through the drive transmission. Sliding adjustment of the position of the sleeve regulates the exposed cross-section of the flow slots, thereby also regulating the open and closed switching of the control valve. The regulating sleeve is the only moving part exposed to the flowing liquid, and the liquid pressure and flow forces act only radially on the axially slidable sleeve, so that the hydraulic forces do not influence the driving force required for opening and closing the valve.

    摘要翻译: 用于低温液化火箭推进剂的电动控制阀包括具有同轴入口和出口的阀壳,可滑动调节套,电动马达,齿轮,壳体内的驱动室,以及驱动传动装置 驱动室。 调节套筒集中布置并可滑动地安装并密封在阀壳体和驱动室中。 流动槽围绕调节套筒周向分布。 外部安装的电机和齿轮通过驱动传动装置控制调节套筒的位置。 套筒的位置的滑动调节调节流槽的暴露横截面,从而也调节控制阀的打开和闭合切换。 调节套筒是仅暴露于流动液体的唯一移动部件,液体压力和流动力仅在径向上作用在可轴向滑动的套筒上,使得液压力不影响打开和关闭阀门所需的驱动力。